| Identifier |
20180305_nanos_hottopic1_01 |
| Title |
What's New in Graves' Orbitopathy? |
| Creator |
Jim Garrity, MD |
| Subject |
Graves' orbitopathy, Thyroid eye disease, Biologic medications, TSH-receptor, IGF-1 receptor |
| Description |
Graves' orbitopathy (GO) is the most frequent extrathyroidal manifestation of Graves' disease (GD). Depending upon the diagnostic criteria used up to 50% of patients with GD have ophthalmic findings; with lid retraction/lid lag being the most common1-3. More severe, sight-threatening disease is seen in approximately 5% of hyperthyroid individuals4. While most GO requires no eye specific treatment,; approximately 15% of GO progress and is of interest to this presentation. |
| Date |
2018-04 |
| Language |
eng |
| Format |
application/pdf |
| Source |
2018 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2018: Hot Topics:What's New in the Orbit? |
| Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
| Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
| Rights Management |
Copyright 2017. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s60p52gd |
| Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
| Contributor Primary |
James A. Garrity MD, Mayo Clinic, Rochester, MN |
| Setname |
ehsl_novel_nam |
| ID |
1315753 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s60p52gd |
